Skip to main content
Top
Published in: BMC Public Health 1/2008

Open Access 01-12-2008 | Research article

Factors associated with improvement in disability-adjusted life years in patients with HIV/AIDS

Authors: Clara Bermudez-Tamayo, Jose Jesus Martin Martin, Isabel Ruiz-Pérez, Antonio Olry de Labry Lima

Published in: BMC Public Health | Issue 1/2008

Login to get access

Abstract

Background

The epidemic of HIV/AIDS and treatments that have emerged to alleviate, have brought about a shift in the burden of disease from death to quality of life/disability. The aim was to determine which factors are associated with improvements in the level of health of male and female patients with HIV/AIDS in Andalusia, in terms of disability-adjusted life years.

Methods

Descriptive study based on a sample group of 8800 people on the Andalusian AIDS register between 1983 and 2004. Dependent variables: Life lost due to premature mortality (YLL), years lost due to disability (YLD) and disability-adjusted life years (DALY). Independent variables: vital state, sex, age at the time of diagnosis, age at the time of death, transmission category, province of residence, AIDS-indicator disease and the period of diagnosis. A bivariate analysis was carried out to find out if the health level variables changed in accordance with the independent variables. Using the independent variables which had a statistically significant link with the level of health variables, a multivariate linear regression model, disaggregated by gender, was constructed.

Results

Amongst the women, we found a model which explained the level of health of 64.9%: a link was found between a higher level of health (lower DALYs) and not intravenous drug use, the province of residence, being diagnosed during the HAART era and older age at the time of diagnosis. Amongst the men, we found a model which explained the level of health of 64.4%: a link was found between a higher level of health (lower DALYs) and intravenous drug use, the province of residence, being diagnosed during the HAART era and older age at the time of diagnosis.

Conclusion

A higher level of health (lower DALY) amongst both men and women was found to be linked to not be intravenous drug user, the province of residence, being diagnosed during the HAART era and older age at the time of diagnosis.
Appendix
Available only for authorised users
Literature
4.
go back to reference Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I, GEMES (Spanish Multicenter Study Group of Seroconverters): Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters. differences by transmission category. AIDS. 2003, 17 (3): 353-359. 10.1097/00002030-200302140-00009.CrossRefPubMed Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I, GEMES (Spanish Multicenter Study Group of Seroconverters): Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters. differences by transmission category. AIDS. 2003, 17 (3): 353-359. 10.1097/00002030-200302140-00009.CrossRefPubMed
5.
go back to reference Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS, CASCADE Collaboration: Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003, 362: 1267-74. 10.1016/S0140-6736(03)14570-9.CrossRefPubMed Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS, CASCADE Collaboration: Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003, 362: 1267-74. 10.1016/S0140-6736(03)14570-9.CrossRefPubMed
6.
go back to reference Brito AM, Castilho EA, Szwarcwald CL: Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis. 2005, 9 (1): 9-19. 10.1590/S1413-86702005000100004.CrossRefPubMed Brito AM, Castilho EA, Szwarcwald CL: Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis. 2005, 9 (1): 9-19. 10.1590/S1413-86702005000100004.CrossRefPubMed
7.
go back to reference Szwarcwald CL, Bastos FI, Barcellos C, Esteves MA, Castilho EA: AIDS epidemic dynamics in the municipality of Rio de Janeiro, Brazil, 1988–1996. Spatial-temporal statistic modelling. Cad Saude Publica. 2001, 17 (5): 1123-40.CrossRefPubMed Szwarcwald CL, Bastos FI, Barcellos C, Esteves MA, Castilho EA: AIDS epidemic dynamics in the municipality of Rio de Janeiro, Brazil, 1988–1996. Spatial-temporal statistic modelling. Cad Saude Publica. 2001, 17 (5): 1123-40.CrossRefPubMed
8.
go back to reference Van Asten L, Zangerle R, Hernandez Aguado I, Boufassa F, Broers B, Brettle RP, Roy Robertson J, McMenamin J, Coutinho RA, Prins M: Do HIV disease progression and HAART response vary among injecting drug users in Europe?. Eur J Epidemio. 2005, 20 (9): 795-804. 10.1007/s10654-005-1049-0.CrossRef Van Asten L, Zangerle R, Hernandez Aguado I, Boufassa F, Broers B, Brettle RP, Roy Robertson J, McMenamin J, Coutinho RA, Prins M: Do HIV disease progression and HAART response vary among injecting drug users in Europe?. Eur J Epidemio. 2005, 20 (9): 795-804. 10.1007/s10654-005-1049-0.CrossRef
9.
go back to reference Giovannetti L, Crocetti E, Chellini E, Martini A, Balocchini E, Costantini AS: Temporal trends in AIDS incidence and mortality in Tuscany (1987–2000)]. Epidemiol Prev. 2004, 28 (2): 100-106.PubMed Giovannetti L, Crocetti E, Chellini E, Martini A, Balocchini E, Costantini AS: Temporal trends in AIDS incidence and mortality in Tuscany (1987–2000)]. Epidemiol Prev. 2004, 28 (2): 100-106.PubMed
10.
go back to reference Jarrin I, Lumbreras B, Ferreros I, Pérez-Hoyos S, Hurtado I, Hernández-Aguado I: Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. Int J Epidemiol. 2007, 36 (1): 187-94. 10.1093/ije/dyl231.CrossRefPubMed Jarrin I, Lumbreras B, Ferreros I, Pérez-Hoyos S, Hurtado I, Hernández-Aguado I: Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. Int J Epidemiol. 2007, 36 (1): 187-94. 10.1093/ije/dyl231.CrossRefPubMed
11.
go back to reference Báez-Feliciano DV, Thomas JC, Gómez MA, Miranda S, Fernández DM, Velázquez M, Ríos-Olivares E, Hunter-Mellado RF: Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Rev Panam Salud Publica. 2005, 17 (2): 92-101. 10.1590/S1020-49892005000200005.CrossRefPubMed Báez-Feliciano DV, Thomas JC, Gómez MA, Miranda S, Fernández DM, Velázquez M, Ríos-Olivares E, Hunter-Mellado RF: Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Rev Panam Salud Publica. 2005, 17 (2): 92-101. 10.1590/S1020-49892005000200005.CrossRefPubMed
12.
go back to reference del Amo J, del Romero J, Barrasa A, Pérez-Hoyos S, Rodríguez C, Díez M, García S, Soriano V, Castilla J, Grupo de Seroconvertores de la Comunidad de Madrid: Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sex Transm Infect. 2002, 78 (4): 255-260. 10.1136/sti.78.4.255.CrossRefPubMedPubMedCentral del Amo J, del Romero J, Barrasa A, Pérez-Hoyos S, Rodríguez C, Díez M, García S, Soriano V, Castilla J, Grupo de Seroconvertores de la Comunidad de Madrid: Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sex Transm Infect. 2002, 78 (4): 255-260. 10.1136/sti.78.4.255.CrossRefPubMedPubMedCentral
13.
go back to reference Ruiz-Pérez I, Olry de Labry-Lima A, López-Ruz MA, del Arco-Jiménez A, Rodríguez-Baño J, Causse-Prados M, Pasquau-Liaño J, Martín-Rico P, Prada-Pardal JL, de la Torre-Lima J, López-Gómez M, Marcos M, Muñoz N, Morales D, Muñoz I: Estado clínico, adherencia al TARGA y calidad de vida en pacientes con infección por el VIH tratados con antirretrovirales. Enferm Infecc Microbiol Clin. 2005, 23 (10): 581-5.CrossRefPubMed Ruiz-Pérez I, Olry de Labry-Lima A, López-Ruz MA, del Arco-Jiménez A, Rodríguez-Baño J, Causse-Prados M, Pasquau-Liaño J, Martín-Rico P, Prada-Pardal JL, de la Torre-Lima J, López-Gómez M, Marcos M, Muñoz N, Morales D, Muñoz I: Estado clínico, adherencia al TARGA y calidad de vida en pacientes con infección por el VIH tratados con antirretrovirales. Enferm Infecc Microbiol Clin. 2005, 23 (10): 581-5.CrossRefPubMed
14.
go back to reference Gold MR, Stevenson D, Fryback DG: HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. Annu Rev Public Health. 2002, 23: 115-134. 10.1146/annurev.publhealth.23.100901.140513.CrossRefPubMed Gold MR, Stevenson D, Fryback DG: HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. Annu Rev Public Health. 2002, 23: 115-134. 10.1146/annurev.publhealth.23.100901.140513.CrossRefPubMed
15.
go back to reference Mathers CD, Murray CJL, Ezzati M, Gakidou E, Salomon JA, Stein C: Population health metrics: crucial inputs to the development of evidence for health policy. Population Health Metrics. 2000, 1: 6-12. 10.1186/1478-7954-1-6.CrossRef Mathers CD, Murray CJL, Ezzati M, Gakidou E, Salomon JA, Stein C: Population health metrics: crucial inputs to the development of evidence for health policy. Population Health Metrics. 2000, 1: 6-12. 10.1186/1478-7954-1-6.CrossRef
16.
go back to reference Schwarzinger M, Stouthard M, Burström K, Nord E, the European Disability Weights Group: Cross-national agreement on disability weights. the European Disability Weights Project. Population Health Metrics. 2003, 1 (9): 12-18. Schwarzinger M, Stouthard M, Burström K, Nord E, the European Disability Weights Group: Cross-national agreement on disability weights. the European Disability Weights Project. Population Health Metrics. 2003, 1 (9): 12-18.
17.
go back to reference Shah R, Bradbeer C: Women and HIV – revisited ten years on. Int J STD AIDS. 2000, 11 (5): 277-83. 10.1258/0956462001915813.CrossRefPubMed Shah R, Bradbeer C: Women and HIV – revisited ten years on. Int J STD AIDS. 2000, 11 (5): 277-83. 10.1258/0956462001915813.CrossRefPubMed
18.
go back to reference Bermúdez MP, Teva I: Situación Actual del SIDA en España: Análisis de las diferencias entre comunidades Autónomas. International Journal of Clinical and Health Psychology. 2004, 4 (3): 553-570. Bermúdez MP, Teva I: Situación Actual del SIDA en España: Análisis de las diferencias entre comunidades Autónomas. International Journal of Clinical and Health Psychology. 2004, 4 (3): 553-570.
19.
go back to reference Mocroft A, Gill MJ, Davidson W, Phillips AN: Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?. J Acquir Immune Defic Syndr. 2000, 24 (5): 475-82.CrossRefPubMed Mocroft A, Gill MJ, Davidson W, Phillips AN: Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?. J Acquir Immune Defic Syndr. 2000, 24 (5): 475-82.CrossRefPubMed
20.
go back to reference Tornero C, Santamaria S, Gil E: Distribución del gasto farmacéutico en medicación antirretoviral. An Med Interna. 2004, 21 (6): 269-71. Tornero C, Santamaria S, Gil E: Distribución del gasto farmacéutico en medicación antirretoviral. An Med Interna. 2004, 21 (6): 269-71.
21.
go back to reference Messori A, Trippoli S, Vaiani M: The cost effectiveness of antiretroviral therapy for HIV disease. N Engl J Med. 2001, 345 (1): 68-70. 10.1056/NEJM200107053450117.CrossRefPubMed Messori A, Trippoli S, Vaiani M: The cost effectiveness of antiretroviral therapy for HIV disease. N Engl J Med. 2001, 345 (1): 68-70. 10.1056/NEJM200107053450117.CrossRefPubMed
22.
go back to reference Anis AH, Hogg RS, Wang XH, Yip B, Palepu A, Montaner JS, O'Shaughnessy MV, Schechter MT: Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy. Pharmacoeconomics. 1998, 13 (6): 697-705. 10.2165/00019053-199813060-00006.CrossRefPubMed Anis AH, Hogg RS, Wang XH, Yip B, Palepu A, Montaner JS, O'Shaughnessy MV, Schechter MT: Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy. Pharmacoeconomics. 1998, 13 (6): 697-705. 10.2165/00019053-199813060-00006.CrossRefPubMed
23.
go back to reference Miners AH, Sabin CA, Trueman P, Youle M, Mocroft A, Johnson M, Beck EJ: Assessing the cost-effectiveness of HAART for adults with HIV in England. HIV Med. 2001, 2 (1): 52-58. 10.1046/j.1468-1293.2001.00048.x.CrossRefPubMed Miners AH, Sabin CA, Trueman P, Youle M, Mocroft A, Johnson M, Beck EJ: Assessing the cost-effectiveness of HAART for adults with HIV in England. HIV Med. 2001, 2 (1): 52-58. 10.1046/j.1468-1293.2001.00048.x.CrossRefPubMed
24.
go back to reference Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ: The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001, 344 (11): 824-831. 10.1056/NEJM200103153441108.CrossRefPubMed Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ: The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001, 344 (11): 824-831. 10.1056/NEJM200103153441108.CrossRefPubMed
25.
go back to reference Anand D, Hanson K: Disability-adjusted life years: a critical review. J Health econ. 1997, 16 (6): 685-702. 10.1016/S0167-6296(97)00005-2.CrossRefPubMed Anand D, Hanson K: Disability-adjusted life years: a critical review. J Health econ. 1997, 16 (6): 685-702. 10.1016/S0167-6296(97)00005-2.CrossRefPubMed
Metadata
Title
Factors associated with improvement in disability-adjusted life years in patients with HIV/AIDS
Authors
Clara Bermudez-Tamayo
Jose Jesus Martin Martin
Isabel Ruiz-Pérez
Antonio Olry de Labry Lima
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2008
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-8-362

Other articles of this Issue 1/2008

BMC Public Health 1/2008 Go to the issue